Related Experiment Video

Updated: Jul 18, 2026

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease

Michael R Batzloff1, Manisha Pandey, Colleen Olive

  • 1The Cooperative Research Centre for Vaccine Technology and the Australian Centre for International Tropical Health and Nutrition, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Brisbane 4029, Australia.

Immunologic Research
|December 19, 2006
PubMed

Insights

Developing a vaccine against Streptococcus pyogenes (group A streptococcus, GAS) is crucial for preventing rheumatic fever and rheumatic heart disease. This review explores M-protein-based vaccines and delivery methods in preclinical research.

Area of Science:

  • * Infectious Diseases
  • * Vaccinology
  • * Microbiology

Background:

  • * Rheumatic fever (RF) and rheumatic heart disease (RHD) are serious postinfectious sequelae of Streptococcus pyogenes (group A Streptococcus, GAS) infection.
  • * These diseases disproportionately affect indigenous populations globally, representing a significant public health challenge.
  • * GAS causes a spectrum of diseases beyond RF and RHD.

Purpose of the Study:

  • * To review M-protein-based subunit vaccine strategies against GAS.
  • * To examine various delivery technologies employed in preclinical vaccine development for GAS.
  • * To assess the current landscape of vaccine candidates targeting M-protein.

Main Methods:

  • * Comprehensive literature review of preclinical studies on GAS M-protein vaccines.
  • * Analysis of different subunit vaccine formulations and antigen presentation methods.
  • * Evaluation of diverse vaccine delivery systems and their efficacy in animal models.

Main Results:

  • * M-protein is a primary target for GAS vaccine development due to its abundance and immunogenicity.
  • * Various subunit vaccine approaches, including recombinant proteins and conjugates, have shown promise.
  • * Different delivery technologies, such as nanoparticles and viral vectors, are being investigated for enhanced immunogenicity.

Conclusions:

  • * M-protein-based subunit vaccines represent a promising strategy to prevent GAS infections and their sequelae.
  • * Optimizing vaccine delivery systems is critical for achieving protective immunity against GAS.
  • * Further preclinical research is essential to advance GAS vaccine candidates towards clinical trials.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...